- Home
- ACRV vs SKIN Comparison
ACRV vs SKIN Comparison
Compare ACRV & SKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- SKIN
- Stock Information
- Founded
- ACRV 2018
- SKIN 1997
- Country
- ACRV United States
- SKIN United States
- Employees
- ACRV N/A
- SKIN N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- SKIN Package Goods/Cosmetics
- Sector
- ACRV Health Care
- SKIN Consumer Discretionary
- Exchange
- ACRV Nasdaq
- SKIN Nasdaq
- Market Cap
- ACRV 73.5M
- SKIN 164.1M
- IPO Year
- ACRV 2022
- SKIN N/A
- Fundamental
- Price
- ACRV $2.24
- SKIN $1.32
- Analyst Decision
- ACRV Strong Buy
- SKIN Hold
- Analyst Count
- ACRV 6
- SKIN 5
- Target Price
- ACRV $21.80
- SKIN $2.50
- AVG Volume (30 Days)
- ACRV 165.0K
- SKIN 771.8K
- Earning Date
- ACRV 05-13-2025
- SKIN 03-12-2025
- Dividend Yield
- ACRV N/A
- SKIN N/A
- EPS Growth
- ACRV N/A
- SKIN N/A
- EPS
- ACRV N/A
- SKIN N/A
- Revenue
- ACRV N/A
- SKIN $334,294,000.00
- Revenue This Year
- ACRV N/A
- SKIN $1.93
- Revenue Next Year
- ACRV N/A
- SKIN $12.41
- P/E Ratio
- ACRV N/A
- SKIN N/A
- Revenue Growth
- ACRV N/A
- SKIN N/A
- 52 Week Low
- ACRV $2.14
- SKIN $0.91
- 52 Week High
- ACRV $11.90
- SKIN $4.48
- Technical
- Relative Strength Index (RSI)
- ACRV 22.41
- SKIN 43.86
- Support Level
- ACRV $5.00
- SKIN $1.25
- Resistance Level
- ACRV $5.65
- SKIN $1.45
- Average True Range (ATR)
- ACRV 0.44
- SKIN 0.11
- MACD
- ACRV -0.33
- SKIN 0.01
- Stochastic Oscillator
- ACRV 2.85
- SKIN 28.57
Stock Price Comparison Chart: ACRV vs SKIN
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.